« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 15, Issue 5
, Pages
632-638
, May 2009
Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status
-
Effect of CD34+ cell dose on the kinetics of platelet engraftment in patients with hematologic malignancies receiving T cell–replete blood and marrow transplantation from HLA-mismatched/haploidentical
Effect of CD34+ cell dose on the kinetics of platelet engraftment in patients with hematologic malignancies receiving T cell–replete blood and marrow transplantation from HLA-mismatched/haploidentical related donors.
-
Effect of disease stage at transplantation on the kinetics of platelet engraftment in patients with hematologic malignancies receiving T cell–replete blood and marrow transplantation from HLA-mismatchEffect of disease stage at transplantation on the kinetics of platelet engraftment in patients with hematologic malignancies receiving T cell–replete blood and marrow transplantation from HLA-mismatched/haploidentical related donors.
Financial disclosure: See Acknowledgments on page 637.
PII: S1083-8791(09)00077-9
doi: 10.1016/j.bbmt.2009.02.001
© 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 15, Issue 5
, Pages
632-638
, May 2009
